title: Reply: To PMID 22614882.
authors.forename: Mikkel
authors.initials: M
authors.lastname: Faurschou
authors.forename: Kerstin
authors.initials: K
authors.lastname: Westman
authors.forename: Niels
authors.initials: N
authors.lastname: Rasmussen
authors.forename: Kirsten
authors.initials: K
authors.lastname: de Groot
authors.forename: Oliver
authors.initials: O
authors.lastname: Flossmann
authors.forename: Peter
authors.initials: P
authors.lastname: Höglund
authors.forename: David
authors.initials: D
authors.lastname: Jayne
mesh_terms: D056648:Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis / Q000188:drug therapy*; D003520:Cyclophosphamide / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008297:Male; D008727:Methotrexate / Q000627:therapeutic use*; D012074:Remission Induction / Q000379:methods*
chemical_list: D007166:Immunosuppressive Agents; D003520:Cyclophosphamide; D008727:Methotrexate